FACTX Mutual Fund

FACTX Mutual Fund

NAV$60.22
See how much of FACTX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing top 50 of 153 holdings · as of Aug 31, 2026
FACTX holdings, by weight
#TickerNameWeightCumulativeMkt valueSectorIndustry
1
LLY
Eli Lilly & CoHealth Care · Pharmaceuticals
7.10%		7.1%$237.13MHealth CarePharmaceuticals
2—Thermo FisherHealth Care · Life Sciences Tools
6.65%		13.8%$222.16MHealth CareLife Sciences Tools
Sector and industry · Pro
3
DHR
Danaher Corp
6.61%		20.4%$221.03M
4
UNH
Unitedhealth Group Inc
3.20%		23.6%$107.09M
5
JNJ
Johnson & Johnson -
3.06%		26.6%$102.35M
6
ABBV
AbbVie Inc.
2.82%		29.4%$94.36M
7
NTRA
Natera Inc
2.75%		32.2%$91.76M
8
MRK
Merck & Company Inc
2.56%		34.8%$85.70M
9
WST
West Pharmaceutical Services Inc
2.54%		37.3%$84.94M
10—Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)
2.28%		39.6%$76.34M
11—Ascendis Pharma A/S
1.97%		41.5%$65.76M
12
ALNY
Alnylam Pharmaceuticals Inc.
1.95%		43.5%$64.99M
13
A
Agilent Technologies Inc
1.81%		45.3%$60.66M
14
TXG
10x Genomics Inc Com Usd 1 Cl A
1.80%		47.1%$60.23M
15
VTRS
Viatris Inc.
1.71%		48.8%$57.12M
16
WAT
Waters Corp.
1.71%		50.5%$57.22M
17
MRNA
Moderna Inc
1.68%		52.2%$56.14M
18
RVMD
Revolution Medicines Inc
1.54%		53.7%$51.39M
19
RGEN
Repligen Corp
1.52%		55.3%$50.67M
20—Jazz Pharmaceuticals Plc
1.47%		56.7%$49.13M
21
GH
Guardant Health, Inc
1.36%		58.1%$45.48M
22
ILMN
Illumina, Inc.
1.25%		59.3%$41.66M
23—Ucb Sa
1.20%		60.5%$40.01M
24
ORKA
Oruka Therapeutics Inc Orka
1.19%		61.7%$39.64M
25
PCVX
Vaxcyte Inc
1.15%		62.9%$38.27M
26—Kiniksa Pharmaceuticals Inte
1.11%		64.0%$37.27M
27
BSX
Boston Scientific Corp.
1.10%		65.1%$36.71M
28
RPRX
Royalty Pharma Plc Class A Ordinary Share
1.10%		66.2%$36.85M
29
ELVN
Enliven Therapeutics Inc
1.09%		67.3%$36.47M
30
GILD
Gilead Sciences
1.00%		68.3%$33.37M
31
COGT
Cogent Biosciences Inc
0.96%		69.2%$32.20M
32
STDM
Sartorius Stedim Biotech S.A. Ord Pour Division
0.95%		70.2%$31.87M
33
LFST
Lifestance Health Group Inc
0.92%		71.1%$30.89M
34
SYRE
Spyre Therapeutics Inc
0.91%		72.0%$30.37M
35
BTSG
Brightspring Health
0.84%		72.9%$28.03M
36
KYMR
Kymera Therapeutics Inccommon Stock
0.83%		73.7%$27.92M
37
AMLX
Amylyx Pharmaceuticals Inc
0.81%		74.5%$27.00M
38
BRKR
Bruker Corp.
0.80%		75.3%$26.69M
39—Xenon Pharmaceuticals Inc
0.77%		76.1%$25.77M
40
INSM
Insmed Inc
0.76%		76.8%$25.34M
41
PRAX
Praxis Precision Medicines Inc
0.73%		77.6%$24.52M
42
HTFL
Heartflow, Inc.
0.71%		78.3%$23.68M
43—Caris Life Sciences Inc
0.70%		79.0%$23.36M
44
DNTH
Dianthus Therapeutics Inc
0.69%		79.7%$23.02M
45
LEGN
Legend Biotech Corp-adr
0.67%		80.3%$22.44M
46—Roivant Sciences Ltd. Common Shares
0.66%		81.0%$22.17M
47
BIIB
Biogen Inc.
0.65%		81.6%$21.66M
48
TWST
Twist Bioscience Corp.
0.65%		82.3%$21.55M
49
VCYT
Veracyte, Inc.
0.65%		82.9%$21.59M
50
MBX
Mbx Biosciences Inc
0.60%		83.5%$20.20M
More holdings · Pro
Not reported for this fund: shares, share changes.
FundXLS Pro
See the other 103 holdings of FACTX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

FACTX Mutual Fund All Holdings

FACTX holdings total 154 positions. The top 10 holdings account for 39.6% of the fund, led by Eli Lilly & Co at 7.1%, Thermo Fisher at 6.7%, Danaher Corporation at 6.6%.

FACTX portfolio concentration is moderate, with the top 10 representing 39.6% of total assets. The largest sector exposure is Health Care at 88.6%.

FACTX sectors provide a detailed breakdown. FACTX overlap shows how holdings compare to other funds in your portfolio.